| Full Name | Ji Young An |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1226 W River St, Boise, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205435757 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WD0400X | Registered Nurse - Diabetes Educator | 44024 (Idaho) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | F10200434 (Idaho) | Primary |
| Entity Name | Unity Health Center, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912221318 PECOS PAC ID: 8325177330 Enrollment ID: O20100601000774 |
News Archive
A stockpile of 2 million doses of vaccine to fight the H5N1 strain of Asian bird flu will be accumulated by the British government.
Inviragen, Inc. presented results of the Phase 1 clinical trial of DENVax conducted in Colombia at the annual American Society of Tropical Medicine and Hygiene (ASTMH) meeting today.
The need for improved monitoring of neurotrauma patients has resulted in the development of a prototype of a novel, multitasking "lab on a tube" at the University of Cincinnati (UC).
BioScale Inc., a privately-held life science company that develops, manufactures and promotes a new generation of protein analytics technology, today announced that it has secured $25 million in its recent financing round. Led by new investor Morningside Venture, this round will be used to expand manufacturing operations and commercial sales of the ViBE protein analytics systems. Also participating in the financing were existing investors New Science Ventures, WFD Ventures, F2 Ventures, and several individual investors
› Verified 2 days ago
| Entity Name | Sterling Provider Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205300407 PECOS PAC ID: 2264773373 Enrollment ID: O20190417001724 |
News Archive
A stockpile of 2 million doses of vaccine to fight the H5N1 strain of Asian bird flu will be accumulated by the British government.
Inviragen, Inc. presented results of the Phase 1 clinical trial of DENVax conducted in Colombia at the annual American Society of Tropical Medicine and Hygiene (ASTMH) meeting today.
The need for improved monitoring of neurotrauma patients has resulted in the development of a prototype of a novel, multitasking "lab on a tube" at the University of Cincinnati (UC).
BioScale Inc., a privately-held life science company that develops, manufactures and promotes a new generation of protein analytics technology, today announced that it has secured $25 million in its recent financing round. Led by new investor Morningside Venture, this round will be used to expand manufacturing operations and commercial sales of the ViBE protein analytics systems. Also participating in the financing were existing investors New Science Ventures, WFD Ventures, F2 Ventures, and several individual investors
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ji Young An, 5030 N Chimney Peak Ave, Meridian, ID 83646-2922 Ph: (208) 713-4770 | Ji Young An, 1226 W River St, Boise, ID 83702-7049 Ph: (208) 331-1155 |
News Archive
A stockpile of 2 million doses of vaccine to fight the H5N1 strain of Asian bird flu will be accumulated by the British government.
Inviragen, Inc. presented results of the Phase 1 clinical trial of DENVax conducted in Colombia at the annual American Society of Tropical Medicine and Hygiene (ASTMH) meeting today.
The need for improved monitoring of neurotrauma patients has resulted in the development of a prototype of a novel, multitasking "lab on a tube" at the University of Cincinnati (UC).
BioScale Inc., a privately-held life science company that develops, manufactures and promotes a new generation of protein analytics technology, today announced that it has secured $25 million in its recent financing round. Led by new investor Morningside Venture, this round will be used to expand manufacturing operations and commercial sales of the ViBE protein analytics systems. Also participating in the financing were existing investors New Science Ventures, WFD Ventures, F2 Ventures, and several individual investors
› Verified 2 days ago
Nora M Suarez, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-2222 | |
Dr. Nancy Jane L'heureux, DNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6259 W Emerald St, Boise, ID 83704 Phone: 208-489-1900 Fax: 208-375-5286 | |
Jennifer Woodburn, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-5015 | |
Carl Ciplinski, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10583 W Lake Hazel Rd, Boise, ID 83709 Phone: 208-302-5950 | |
Kathryn Laura Cnossen, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8000 S Federal Way, Boise, ID 83716 Phone: 208-368-2109 | |
Mrs. Chelsea Rose Wallace, RN, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 9976 W Emerald St, Boise, ID 83704 Phone: 208-229-3742 | |
Natasha Michele King-anderson, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 707 N Armstrong Pl, Boise, ID 83704 Phone: 208-375-5211 |